Nova Patents
NO951192L

Pulmonary delivery of active fragments of parathyroid hormone

Abstract

Systemic delivery of parathyroid hormone to a mammalian host is accomplished by inhalation through the mouth of a dispersion of an N-terminal fragment of PTH. It has been found that such respiratory delivery of the PTH fragment provides a pulsatile concentration profile of the PTH in the host's serum. PTH fragment compositions include dry powder formulations having the PTH present in a dry bulking powder, liquid solutions or suspensions suitable for nebulization, and aerosol propellants suitable for use in a metered dose inhaler.

Term

No projected expiry on record.

  1. Priority
  2. Filed and published
  3. Today

375 members in 46 offices

This recordMember, by publication datePriority claim36 more offices are in the list below

Priority claims8

Priority claims
DocumentOfficeKindDate
95339792United States of AmericaA
95339792United States of AmericaA
9309270United States of AmericaW
9309270United States of AmericaW
953397–––
US19920953397–––
US9309270–––
WO1993US09270–––

Members375

Family members, oldest first
DocumentOfficeKind
CA2112674A1CanadaA1
CA2444415A1CanadaA1
WO9300951A1World Intellectual Property Organization (WIPO)A1
AU2309192AAustraliaA
CA2145418A1CanadaA1
WO9407514A1World Intellectual Property Organization (WIPO)A1
EP0592540A1European Patent Office (EPO)A1
AU5349694AAustraliaA
KR940701282ARepublic of KoreaA
EP0592540A4European Patent Office (EPO)A4
JPH07501231AJapanA
NO951192D0NorwayD0
NO951192LThis recordNorwayL
FI951465AFinlandA
IL112618D0IsraelD0
CA2183577A1CanadaA1
WO9524183A1World Intellectual Property Organization (WIPO)A1
AU662919B2AustraliaB2
AU1744995AAustraliaA
US5458135AUnited States of AmericaA
EP0679088A1European Patent Office (EPO)A1
CZ80395A3CzechiaA3
CA2190502A1CanadaA1
WO9531479A1World Intellectual Property Organization (WIPO)A1
AU2514295AAustraliaA
ZA951883BSouth AfricaB
IL115369D0IsraelD0
PE48995A1PeruA1
EP0679088A4European Patent Office (EPO)A4
CA2200727A1CanadaA1
CA2555600A1CanadaA1
CA2606600A1CanadaA1
WO9609085A1World Intellectual Property Organization (WIPO)A1
AU3553295AAustraliaA
JPH08504756AJapanA
ZA957933BSouth AfricaB
FI963468AFinlandA
NO963745D0NorwayD0
TW287110BTaiwan Province of ChinaB
CA2218116A1CanadaA1
CA2218208A1CanadaA1
WO9632116A1World Intellectual Property Organization (WIPO)A1
WO9632149A1World Intellectual Property Organization (WIPO)A1
WO9632152A1World Intellectual Property Organization (WIPO)A1
AU5482596AAustraliaA
AU5482796AAustraliaA
AU5743996AAustraliaA
NO963745LNorwayL
NZ257212ANew ZealandA
HU9602454D0HungaryD0
EP0748213A1European Patent Office (EPO)A1
RU95112536ARussian FederationA
PL316199A1PolandA1
US5607915AUnited States of AmericaA
EP0759939A1European Patent Office (EPO)A1
FI971173AFinlandA
NO971316D0NorwayD0
KR970701534ARepublic of KoreaA
CZ260096A3CzechiaA3
PE16397A1PeruA1
NO20063519LNorwayL
NO20080655LNorwayL
NO971316LNorwayL
HUT75676AHungaryA
MX9603936AMexicoA
CN1151168AChinaA
CN1152867AChinaA
KR970703366ARepublic of KoreaA
PL319505A1PolandA1
BR9507023ABrazilA
CN1160358AChinaA
KR970706033ARepublic of KoreaA
CZ72397A3CzechiaA3
CA2253393A1CanadaA1
WO9741833A1World Intellectual Property Organization (WIPO)A1
AU3119097AAustraliaA
JPH10500672AJapanA
JPH10501519AJapanA
MX9707854AMexicoA
MX9707855AMexicoA
EP0748213A4European Patent Office (EPO)A4
EP0825885A1European Patent Office (EPO)A1
AU688283B2AustraliaB2
AU689217B2AustraliaB2
US5740794AUnited States of AmericaA
CA2274758A1CanadaA1
WO9816205A2World Intellectual Property Organization (WIPO)A2
NZ281112ANew ZealandA
MX9702117AMexicoA
AU5083498AAustraliaA
ZA979145BSouth AfricaB
EP0759939A4European Patent Office (EPO)A4
MX9605717AMexicoA
BR9508964ABrazilA
EP0846009A1European Patent Office (EPO)A1
US5775320AUnited States of AmericaA
US5780014AUnited States of AmericaA
HUT77691AHungaryA
NZ285664ANew ZealandA
US5785049AUnited States of AmericaA
Showing 100 of 375